Giulia Magrini

Medicine & Life Sciences

1. Heart Failure 100%
2. Cardiac Resynchronization Therapy 63%
3. Right Ventricular Function 56%
4. Dilated Cardiomyopathy 56%
5. Ventricular Remodeling 50%
6. Endarterectomy 41%
7. Pulmonary Hypertension 40%
8. Brain Natriuretic Peptide 36%
9. Heart Transplantation 34%
10. Italy 34%
11. Tertiary Care Centers 31%
12. Heart Ventricles 30%
13. Left Ventricular Dysfunction 26%
14. Nebivolol 25%
15. Hemodynamics 24%
16. Perindopril 23%
17. Vascular Resistance 23%
18. Echocardiography 22%
19. Elderly 22%
20. Familial Primary Pulmonary Hypertension 21%
21. Stroke Volume 21%
22. Cardiac Catheterization 19%
23. Atrial Heart Septal Defects 19%
24. Coronary Sinus 19%
25. Heart-Assist Devices 19%
26. Emergency Medicine 19%
27. Myocarditis 18%
28. Mitral Valve Insufficiency 17%
29. Lung 17%
30. Mitochondrial DNA 17%
31. Internal Medicine 16%
32. Names 15%
33. Tricuspid Valve Insufficiency 15%
34. Muscle Cells 15%
35. Multicenter Studies 14%
36. Veins 13%
37. Myocardial Infarction 11%
38. Right Ventricular Dysfunction 11%
39. Angiotensin-Converting Enzyme Inhibitors 11%
40. Pulmonary Wedge Pressure 10%
41. Therapeutics 9%
42. Heart 9%
43. Mutation 9%
44. Biopsy 8%
45. Pulmonary Artery 8%
46. Equipment and Supplies 7%
47. Lead 7%
48. Left Ventricular Function 7%
49. Lung Transplantation 7%
50. Pharmacology 6%